Lindsay R Clark Selected Research

Dementia (Dementias)

10/2023	Whole genome methylation sequencing in blood identifies extensive differential DNA methylation in late-onset dementia due to Alzheimer's disease.
7/2023	Feasibility of virtual Alzheimer's biomarker disclosure: Findings from an observational cohort.
1/2023	Informing Disclosure: Efficacy of a Brief Educational Intervention on Research Participants' Knowledge about Alzheimer's Disease Biomarkers.
1/2022	Implications of preclinical Alzheimer's disease biomarker disclosure for US policy and society.
1/2022	Associations of the Lifestyle for Brain Health index with longitudinal cognition and brain amyloid beta in clinically unimpaired older adults: Findings from the Wisconsin Registry for Alzheimer's Prevention.
1/2021	Validity Evidence for the Research Category, "Cognitively Unimpaired - Declining," as a Risk Marker for Mild Cognitive Impairment and Alzheimer's Disease.
4/2015	Susceptibility of the conventional criteria for mild cognitive impairment to false-positive diagnostic errors.
1/2014	Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lindsay R Clark Research Topics

Disease

27	Alzheimer Disease (Alzheimer's Disease) 03/2024 - 08/2012
22	Cognitive Dysfunction 10/2022 - 08/2012
8	Dementia (Dementias) 10/2023 - 01/2014
3	Atrophy 07/2019 - 12/2015
2	Obesity 01/2020 - 01/2019
2	Inflammation (Inflammations) 02/2019 - 01/2016
1	Huntington Disease (Huntington's Disease) 10/2022
1	Amyloid Plaque 01/2022
1	Amyloidosis 12/2019
1	Abdominal Obesity 01/2019
1	Hypertension (High Blood Pressure) 01/2019

Drug/Important Bio-Agent (IBA)

27	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2014
13	Amyloid (Amyloid Fibrils)IBA 07/2023 - 01/2016
6	Apolipoproteins E (ApoE)IBA 01/2019 - 08/2012
4	ApolipoproteinsIBA 01/2022 - 01/2018
2	Unithiol (DMPS)IBA 10/2023 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 01/2018
2	Amyloid beta-PeptidesIBA 01/2022 - 01/2016
2	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2017
2	NeurograninIBA 02/2019 - 01/2019
2	Tumor Necrosis Factor Ligand Superfamily Member 14IBA 01/2019 - 10/2016
1	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 01/2020
1	CholesterolIBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 02/2019
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 05/2017
1	Apolipoprotein E4IBA 10/2016

Therapy/Procedure

1	Therapeutics 05/2017